Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Prurigo Nodularis Treatment Market Scripts Growth with Surged Adoption of Antihistamines as Potential Drug

Press release Description

Albany, New York, October 25, 2018: Characterized by acute itching and lump formation on the skin, prurigo nodularis is a rare disease. Rising incidences of such rare conditions worldwide has encouraged advancement in prurigo nodularis therapeutics development. In its recent business intelligence report titled, ‘Prurigo Nodularis Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028‘, Market Research Reports Search Engine (MRRSE) delves deep in understanding ongoing market developments and their eventual implications on overall growth of prurigo nodularis therapeutics development.

Strategic Collaborations to Accelerate R&D Initiatives for Prurigo Nodularis Drug Development

Leading biopharmaceutical companies in addition to research organizations have driven massive investments towards novel treatment procedure to meet growing unmet medical needs across the globe pertaining to prurigo nodularis. Advanced treatment methodologies such as laser therapy, cryotherapy, and photochemotherapy have recorded significant success as potent treatment for prurigo nodularis treatment. Leading industry veterans are akin on investing substantially in R&D initiatives to aid new product launch, besides banking upon strategic business collaborations to hold market lead.

Menlo Therapeutics Launches Phase 3 Trial of Serlopitant for Prurigo Nodularis Treatment

Followed by successful phase two trial of serlopitant, Menlo Therapeutics has announced the launch of phase three trial of the drug to treat prurigo nodularis. With such novel breakthroughs in drug development prurigo nodularis treatment market is expected to attain new growth spots.

Retail Pharmacies Distribution Channel Likely to Influence Revenue Share in Prurigo Nodularis Treatment Market

In the subsequent paragraphs, this research report on prurigo nodularis treatment market offers a comprehensive review of various market segments that influence market growth. The market identifies product type and distribution channel as core segments in prurigo nodularis treatment market. Based on product type the market is classified into corticosteroids, emollients, capsacin cream, antihistamines amongst others. On the basis of distribution channel prurigo nodularis treatment market is diversified into hospital pharmacies, retail pharmacies, and online pharmacies.

Western Europe Emerges as the Largest Regional Market for Prurigo Nodularis Treatment

Additionally, the report further entails crucial business highlights on regional diversification of prurigo nodularis market based on which the market is splintered into Eastern and Western Europe, North America, Latin America, Asia-Pacific excluding Japan and China, Middle East and Africa, Japan, and China.

Competition Deep-Dive: Prurigo Nodularis Treatment Market

In-depth research elements included in the report allow readers to gauge the efficacy of marketing strategies implemented by leading market players in enticing favorable consumer response with regards to their purchase decisions. Elaborate analysis of these winning strategies by leading market players allows them to infer core deductions based on which market players can facilitate lucrative investment decisions. Some of the leading players in prurigo nodularis treatment market comprise Bayer AG, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi SA, Takeda Pharmaceutical Company Limited amongst others

Browse Full Global Prurigo Nodularis Treatment Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559